# Identification of Biomarkers of Janus Kinase Inhibitor Therapy in Patients With Ulcerative Colitis

> **NCT04576000** · — · TERMINATED · sponsor: **Alimentiv Inc.** · enrollment: 3 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** Janus Kinase Inhibitor

## Key facts

- **NCT ID:** NCT04576000
- **Lead sponsor:** Alimentiv Inc.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2020-08-25
- **Primary completion:** 2020-12-15
- **Final completion:** 2021-12-02
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Not able to meet recruitment targets
- **Last updated:** 2022-01-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04576000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04576000, "Identification of Biomarkers of Janus Kinase Inhibitor Therapy in Patients With Ulcerative Colitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04576000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*